Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Next generation immunotherapies for hard-to-treat |
Description | Powerful. Next generation immunotherapies for hard-to-treat cancers that are allogeneic and |
Keywords | N/A |
WebSite | gemoab.com |
Host IP | 198.49.23.144 |
Location | United States |
Site | Rank |
US$330,801
Last updated: 2023-05-07 03:36:49
gemoab.com has Semrush global rank of 31,996,051. gemoab.com has an estimated worth of US$ 330,801, based on its estimated Ads revenue. gemoab.com receives approximately 38,170 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, gemoab.com is safe to visit. |
Purchase/Sale Value | US$330,801 |
Daily Ads Revenue | US$306 |
Monthly Ads Revenue | US$9,161 |
Yearly Ads Revenue | US$109,928 |
Daily Unique Visitors | 2,545 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
gemoab.com. | A | 3600 | IP: 198.49.23.144 |
gemoab.com. | A | 3600 | IP: 198.49.23.145 |
gemoab.com. | A | 3600 | IP: 198.185.159.144 |
gemoab.com. | A | 3600 | IP: 198.185.159.145 |
gemoab.com. | NS | 3600 | NS Record: ns1.first-ns.de. |
gemoab.com. | NS | 3600 | NS Record: robotns3.second-ns.com. |
gemoab.com. | NS | 3600 | NS Record: robotns2.second-ns.de. |
gemoab.com. | MX | 3600 | MX Record: 10 mx0.gemoab.com. |
gemoab.com. | TXT | 3600 | TXT Record: v=spf1 mx ~all |
About Leadership Board Science Universal Switchable CAR Allogeneic Platform TCE Publications Pipeline Careers News Contact Menu About Leadership Board Science Universal Switchable CAR Allogeneic Platform TCE Publications Pipeline Careers News Contact Linkedin-in Powerful. Persistent. Switchable. Next generation immunotherapies for hard-to-treat cancers. explore our science Allogeneic + Switchable Addressing the shortcomings of current T cell-based immunotherapies with powerful, targeted, safe technology. Powerful Proprietary platforms allow for powerful controllability of CAR-T reactivity while maintaining high anti-tumor activity that prevents T-effector cell exhaustion and immune-suppression. Targeted Switchable on/off mechanism made possible by combining a universal effector cell with soluble adaptors called Targeting Modules (TMs) allows for precise targeting of cancer antigens. Safe Rapid switchability lowers the risk for acute and long-term CRS-related and other side |
HTTP/1.1 301 Moved Permanently Age: 0 Date: Wed, 27 Oct 2021 06:19:28 GMT Location: https://www.gemoab.com/ Server: Squarespace Set-Cookie: crumb=BWkaRdYS0nN1ZjU3MGJjNzEwMTg5MjMxNTUyMDEzM2MwOWQ2MDFl;Path=/ X-Contextid: W9nnuscI/8uXNfTSB HTTP/2 200 accept-ranges: bytes age: 341979 content-type: text/html;charset=utf-8 date: Sat, 23 Oct 2021 07:19:48 GMT etag: W/"9d5443336732d132e6b7cec64a4a80e7" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BROmIz7hDxDFYTczYmQ2ZDllYjVjZjQ0NDZlNDkxMWU3NzM5N2Q1;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: d0eQXuUK/Hihfsow0 content-length: 16101 |
Domain Name: GEMOAB.COM Registry Domain ID: 1843936512_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.your-server.de Registrar URL: http://www.hetzner.com Updated Date: 2021-01-24T08:14:10Z Creation Date: 2014-01-23T12:27:45Z Registry Expiry Date: 2022-01-23T12:27:45Z Registrar: Hetzner Online GmbH Registrar IANA ID: 828 Registrar Abuse Contact Email: abuse@hetzner.com Registrar Abuse Contact Phone: +49 9831 5050 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.FIRST-NS.DE Name Server: ROBOTNS2.SECOND-NS.DE Name Server: ROBOTNS3.SECOND-NS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T04:01:34Z <<< |